Clinical Predictors of Transient Ischemic Attack, Stroke, or Death within 30 Days of Carotid Artery Stent Placement with Distal Balloon Protection

Journal of Vascular and Interventional Radiology

Volumn 20, Issue 1, 2009, Pages 9-16

  Kawabata, Yasuhiro ^a   Sakai, Nobuyuki ^b   Nagata, Izumi ^c   Horikawa, Fumihiko ^a   Miyake, Hidenori ^a   Ueno, Yasushi ^a,b   Kikuchi, Haruhiko ^b  

^a HAMAMATSU ROSAI HOSPITAL   (Japan)

^b KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^c NAGASAKI UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TICLOPIDINE;

ADULT; AGED; APHASIA; ARTICLE; BALLOON OCCLUSION; BRADYCARDIA; BRAIN ISCHEMIA; CAROTID ARTERY; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CONSCIOUSNESS DISORDER; CONTROLLED STUDY; DEATH; FEMALE; HEART INFARCTION; HEMIPARESIS; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK FACTOR; SEIZURE; STENT; STROKE; TRANSIENT ISCHEMIC ATTACK;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOGRAPHY, DIGITAL SUBTRACTION; ANGIOPLASTY, BALLOON; BALLOON OCCLUSION; CAROTID STENOSIS; ENDARTERECTOMY, CAROTID; EQUIPMENT DESIGN; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STENTS; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 57749096248     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2008.10.008     Document Type: Article

References (49)

1. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 325 (1991) 445-453
2. ECST Collaborative Group. Randomized trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 351 (1998) 1379-1387
3. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 273 (1995) 1421-1428
4. Halliday A., Mansfield A., Marro J., et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomized controlled trial. Lancet 363 (2004) 1491-1502
5. US Food and Drug Administration. Summary of Safety and Effectiveness Data, Acculink Carotid Stent System and Rx Acculink Carotid Stent System, Guidant Corporation, PMA# P040012. http://www.fda.gov/cdrh/mda/docs/p040012.html Accessed August 30, 2004.
6. US Food and Drug Administration. Summary of Safety and Effectiveness Data, Xact Carotid Stent System, Abbott Vascular Devices, PMA# P040038. http://www.fda.gov/cdrh/mda/docs/p040038.html Accessed September 6, 2005.
7. Mas J.L., Chatellier G., Beyssen B., et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 355 (2006) 1660-1771
8. Theiss W., Hermanek P., Mathias K., et al. Pro-CAS: a prospective registry of carotid angioplasty and stenting. Stroke 35 (2004) 2134-2139
9. White C.J., Lyer S.S., Hopkins L.N., et al. Carotid stenting with distal protection in high surgical risk patients: the BEACH trial 30 day results. Cathet Cardiovasc Intervent 67 (2006) 503-512
10. Brooks W.H., McClure R.R., Hones M.R., et al. Carotid angioplasty and stenting versus carotid endarterectomy: randomized trial in a community hospital. J Am Coll Cardiol 38 (2001) 1589-1595
11. CaRESS Steering Committee. Carotid Revascularization using Endarterectomy or Stenting Systems (CaRESS) phase I clinical trial: 1-year results. J Vasc Surg 42 (2005) 213-219
12. Yadav J.S., Wholey M.H., Kuntz R.E., et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 351 (2004) 1493-1501
13. Bates E.R., Babb J.D., Casey D.E., et al. ACCF/SCAI/SVMB/SIR/ASITN 2007. Clinical expert consensus document on carotid stenting. J Am Coll Cardiol 49 (2007) 126-170
14. Parodi J.C., La Mura R., Ferreira M., et al. Initial evaluation of carotid angioplasty and stenting with three different cerebral protection devices. J Vasc Surg 32 (2000) 1127-1136
15. Powell R.J., Allessi C., Nolan B., et al. Comparison of embolization protection device-specific technical difficulties during carotid artery stenting. J Vasc Surg 44 (2006) 56-61
16. Parodi J.C., Schonholz C., Ferreira M., et al. "Seat Belt and Air Bag" technique for cerebral protection during carotid stenting. J Endovasc Ther 9 (2002) 20-24
17. Al-Mubarak N., Roubin G.S., Vitek J.J., et al. Effect of the distal-balloon protection system on microembolization during carotid stenting. Circulation 104 (1999) 1999-2002
18. Chaer R., Trocciola S., DeRubertis B., et al. Cerebral ischemia associated with GuardWire balloon occlusion balloon during carotid stenting: incidence and possible mechanisms. J Vasc Surg 43 (2006) 946-952
19. Henry M., Henry I., Klonaris C., et al. Benefits of cerebral protection during carotid stenting with the PercuSurge GuardWire system: midterm results. J Endovasc Ther 9 (2002) 1-13
20. Martin J.B., Pache J.C., Treggiri-Venzi M., et al. Role of the distal balloon protection technique in the prevention of cerebral embolic events during carotid stent placement. Stroke 32 (2001) 479-484
21. Al-Mubarak N., Colombo A., Gaines P.A., et al. Multicenter evaluation of carotid artery stenting with a filter protection system. J Am Coll Cardiol 39 (2002) 841-846
22. Macdonald S., McKevitt F., Venables G.S., et al. Neurological outcomes after carotid stenting protected with the NeuroShield filter compared to unprotected stenting. J Endovasc Ther 9 (2002) 777-785
23. Kwon B.J., Han M.H., Kang H.S., et al. Protection filter-related events in extracranial carotid artery stenting: a single-center experience. J Endovasc Ther 13 (2006) 711-722
24. Safian R.D., Bresnahan J.F., Jaff M.R., et al. Protected carotid stenting in high-risk patients with severe carotid artery stenosis. J Am Coll Cardiol 47 (2006) 2384-2389
25. Kasirajan K., Schneider P.A., and Kent K.C. Filter devices for cerebral protection during carotid angioplasty and stenting. J Endovasc Ther 10 (2003) 1039-1045
26. Reimers B., Sievert H., Schuler G.C., et al. Proximal endovascular flow blockage for cerebral protection during carotid artery stenting: results from a prospective multicenter registry. J Endovasc Ther 12 (2005) 156-165
27. Asakura F., Kawaguchi K., Sakaida H., et al. Diffusion-weighted MR imaging in carotid angioplasty and stenting with protection by the reversed carotid arterial flow. AJNR Am J Neuroradiol 27 (2006) 753-758
28. Cremonesi A., Manetti F., Liso A., et al. Endovascular treatment of soft carotid plaques: a single-center carotid stent experience. J Endovasc Ther 13 (2006) 190-195
29. Yadav J.S. New insights into improving acute and long-term outcomes of carotid stenting. J Am Coll Cardiol 47 (2006) 2397-2398
30. Ahmadi R., Schillinger M., Lang W., et al. Carotid artery stenting in older patients: is age a risk factor for poor outcome?. J Endovasc Ther 9 (2002) 559-565
31. Qureshi A.I., Luft A.R., Janardhan V., et al. Identification of patients at risk for periprocedural neurological deficits associated with carotid angioplasty and stenting. Stroke 31 (2000) 376-382
32. Lam R.C., Lin S.C., DeRubertis B., et al. The impact of increasing age on anatomic factors affecting carotid angioplasty and stenting. J Vasc Surg 45 (2007) 875-880
33. Hobson R.W., Howard V.J., Robin G.S., et al. Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase. J Vasc Surg 40 (2004) 1106-1111
34. Kastrup A., Groschel K., Schulz J.B., et al. Clinical predictors of transient ischemic attack, stroke, or death within 30 days of carotid angioplasty and stenting. Stroke 36 (2005) 787-791
35. Alamowithc S., Eliasziw M., Algra A., et al. Risk, causes, and prevention of ischemic stroke in elderly patients with symptomatic internal-carotid-artery stenosis. Lancet 357 (2001) 1154-1160
36. Rothwell P.M., Eliasziw M., Gutnikov S.A., et al. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 363 (2004) 915-924
37. The SPACE Collaborative Group. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomized non-inferiority trial. Lancet 368 (2006) 1239-1247
38. Saam T., Hatsukami T.S., Takaya N., et al. The vulnerable, or high-risk, atherosclerotic plaque: noninvasive MR imaging for characterization and assessment. Radiology 244 (2007) 64-77
39. Naghavi M., Libby P., Falk E., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation 108 (2003) 1664-1672
40. Takaya N., Yuan C., Chu B., et al. Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI - initial results. Stroke 37 (2006) 818-823
41. Altaf N., MacSweeney S.T., Gladman J., et al. Carotid intraplaque hemorrhage predicts recurrent symptoms in patients with high-grade carotid stenosis. Stroke 38 (2007) 1633-1635
42. Saam T., Cai J., Ma L., et al. Comparison of symptomatic and asymptomatic atherosclerotic carotid plaque features with in vivo MR imaging. Radiology 240 (2006) 464-472
43. Hart J.P., Petter P., Verbist J., et al. Do device characteristics impact outcome in carotid artery stenting?. J Vasc Surg 44 (2006) 725-730
44. Taylor A.J., Kent S.M., Flaherty P.J., et al. ARBITER: arterial biology for the investigation of the treatment effects of reducing cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness. Circulation 106 (2002) 2055-2060
45. Crisby M., Nordon-Fredriksson G., Shah P.K., et al. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques. Implications for plaque stabilization. Circulation 103 (2001) 926-933
46. McGirt M., Perler B., Brooke B., et al. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy. J Vasc Surg 42 (2005) 829-836
47. Gröschel K., Ernemann U., Schulz J.B., et al. Statin therapy at carotid angioplasty and stent placement: effect on procedure-related stroke, myocardial infarction, and death. Radiology 240 (2006) 145-151
48. Matsen S.L., Chang D.C., Perler B.A., et al. Trends in the in-hospital stroke rate following carotid endarterectomy in California and Maryland. J Vasc Surg 44 (2006) 488-495
49. Kragsterman B., Pärsson H., Lindback J., et al. Outcomes of carotid endarterectomy for asymptomatic stenosis in Sweden are improving: results from a population-based registry. J Vasc Surg 44 (2006) 79-85